Biochemical tests performed after surgery because of the patient’s Down’s syndrome condition showed severe primary hypothyroidism, LH suppression, elevated estrogen, and hyperlipidemia (Table 1). This evidence concerns the gene PLOD1 and Primary hypothyroidism.